Intervention not reported
Adverse events · people with ALS/MND
1 finding from 1 review
Intervention not reported
Anatomic success (i.e. patent lacrimal passage after a period of at least six months after operation) · People with nasolacrimal duct obstruction
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
Subjective success (i.e. resolution of symptoms of watering following surgery) · People with nasolacrimal duct obstruction
1 finding from 1 review
no estimate extracted
5 participants
Low
Intervention not reported
Intraoperative bleeding · People with nasolacrimal duct obstruction
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
Postoperative bleeding · People with nasolacrimal duct obstruction
It is very uncertain whether the intervention changes postoperative bleeding (very low certainty).
1 finding from 1 review
Intervention not reported
Wound infection/gaping · People with nasolacrimal duct obstruction
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
Occurrence of CIN2+ in histology at 18 months · women with ASCUS or LSIL
The intervention probably leads to higher occurrence of CIN2+ in histology at 18 months (moderate certainty).
1 finding from 1 review
Intervention not reported
Occurrence of CIN2+ in histology at 24 months · women with ASCUS or LSIL
The intervention showed no clear difference in occurrence of CIN2+ in histology at 24 months (low certainty).
1 finding from 1 review
Intervention not reported
Occurrence of CIN3+ in histology at 18 months · women with ASCUS or LSIL
The intervention showed no clear difference in occurrence of CIN3+ in histology at 18 months (moderate certainty).
1 finding from 1 review
Intervention not reported
Occurrence of CIN3+ in histology at 24 months · women with ASCUS or LSIL
The intervention showed no clear difference in occurrence of CIN3+ in histology at 24 months (low certainty).
1 finding from 1 review
Intervention not reported
Occurrence of any CIN in histology at 24 months · women with ASCUS or LSIL
The intervention may leads to higher occurrence of any CIN in histology at 24 months (low certainty).
1 finding from 1 review
Intervention not reported
Default rates at 6 months · women with ASCUS or LSIL
The intervention probably leads to higher default rates at 6 months (moderate certainty).
1 finding from 1 review
Intervention not reported
Default rates at 12 months · women with ASCUS or LSIL
The intervention probably leads to higher default rates at 12 months (moderate certainty).
1 finding from 1 review
1‐year mortality · previously untreated patients with mRCC
Interferon‐α alone probably leads to higher 1‐year mortality compared with standard targeted therapies (sunitinib or temsirolimus) (moderate certainty).
1 finding from 1 review
Adverse events (grade ≥ 3) · previously untreated patients with mRCC
Interferon‐α combined with targeted therapies may leads to higher adverse events (grade ≥ 3) compared with standard targeted therapy (low certainty).
1 finding from 1 review
1‐year mortality · previously untreated patients with mRCC
Interferon‐α alone showed no clear difference in 1‐year mortality compared with interferon‐α plus bevacizumab (low certainty).
1 finding from 1 review
Quality of life · previously untreated patients with mRCC
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events (grade ≥ 3) · previously untreated patients with mRCC
Interferon‐α alone probably leads to lower adverse events (grade ≥ 3) compared with interferon‐α plus bevacizumab (moderate certainty).
1 finding from 1 review
Death (all causes) · previously untreated patients with mRCC
Interferon‐α plus bevacizumab showed no clear difference in 1‐year mortality median compared with standard targeted therapies (low certainty).
1 finding from 1 review
Quality of life · previously untreated patients with mRCC
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found